Genome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System

被引:10
|
作者
Ipoutcha, Thomas [1 ]
Rideau, Fabien [1 ]
Gourgues, Geraldine [1 ]
Arfi, Yonathan [1 ]
Lartigue, Carole [1 ]
Blanchard, Alain [1 ]
Sirand-Pugnet, Pascal [1 ]
机构
[1] Univ Bordeaux, UMR BFP, INRAE, Villenave Dornon, France
关键词
CRISPR-Cas9; mycoplasma; animal pathogens; minimal cell; genome editing; TARGETED HOMOLOGOUS RECOMBINATION; SPIROPLASMA-CITRI; TRANSPOSON MUTAGENESIS; GENE DISRUPTION; ORIC PLASMIDS; GALLISEPTICUM; DNA; PATHOGENICITY; IDENTIFICATION; CYTADHERENCE;
D O I
10.1128/aem.00996-22
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mycoplasmas are minimal pathogenic bacteria that infect a wide range of hosts, including humans, livestock, and wild animals. Major pathogenic species cause acute to chronic infections involving still poorly characterized virulence factors. Mycoplasmas are minimal bacteria that infect humans, wildlife, and most economically relevant livestock species. Mycoplasma infections cause a large range of chronic inflammatory diseases, eventually leading to death in some animals. Due to the lack of efficient recombination and genome engineering tools for most species, the production of mutant strains for the identification of virulence factors and the development of improved vaccine strains is limited. Here, we demonstrate the adaptation of an efficient Cas9-Base Editor system to introduce targeted mutations into three major pathogenic species that span the phylogenetic diversity of these bacteria: the avian pathogen Mycoplasma gallisepticum and the two most important bovine mycoplasmas, Mycoplasma bovis and Mycoplasma mycoides subsp. mycoides. As a proof of concept, we successfully used an inducible SpdCas9-pmcDA1 cytosine deaminase system to disrupt several major virulence factors in these pathogens. Various induction times and inducer concentrations were evaluated to optimize editing efficiency. The optimized system was powerful enough to disrupt 54 of 55 insertion sequence transposases in a single experiment. Whole-genome sequencing of the edited strains showed that off-target mutations were limited, suggesting that most variations detected in the edited genomes are Cas9-independent. This effective, rapid, and easy-to-use genetic tool opens a new avenue for the study of these important animal pathogens and likely the entire class Mollicutes. IMPORTANCE Mycoplasmas are minimal pathogenic bacteria that infect a wide range of hosts, including humans, livestock, and wild animals. Major pathogenic species cause acute to chronic infections involving still poorly characterized virulence factors. The lack of precise genome editing tools has hampered functional studies of many species, leaving multiple questions about the molecular basis of their pathogenicity unanswered. Here, we demonstrate the adaptation of a CRISPR-derived base editor for three major pathogenic species: Mycoplasma gallisepticum, Mycoplasma bovis, and Mycoplasma mycoides subsp. mycoides. Several virulence factors were successfully targeted, and we were able to edit up to 54 target sites in a single step. The availability of this efficient and easy-to-use genetic tool will greatly facilitate functional studies of these economically important bacteria.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae
    Generoso, Wesley Cardoso
    Gottardi, Manuela
    Oreb, Mislay
    Boles, Eckhard
    JOURNAL OF MICROBIOLOGICAL METHODS, 2016, 127 : 203 - 205
  • [22] Development of CRISPR-Cas systems for genome editing and beyond
    Zhang, F.
    QUARTERLY REVIEWS OF BIOPHYSICS, 2019, 52
  • [23] Application of the CRISPR/Cas system for genome editing in microalgae
    Zhang, Yu-Ting
    Jiang, Jia-Yi
    Shi, Tian-Qiong
    Sun, Xiao-Man
    Zhao, Quan-Yu
    Huang, He
    Ren, Lu-Jing
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (08) : 3239 - 3248
  • [24] CRISPR/Cas Genome Editing in Filamentous Fungi
    Rozhkova, Aleksandra M.
    Kislitsin, Valeriy Yu
    BIOCHEMISTRY-MOSCOW, 2021, 86 (SUPPL 1) : S120 - S139
  • [25] Genome Editing by CRISPR-Cas: A Game Change in the Genetic Manipulation of Chlamydomonas
    Ghribi, Manel
    Nouemssi, Serge Basile
    Meddeb-Mouelhi, Fatma
    Desgagne-Penix, Isabel
    LIFE-BASEL, 2020, 10 (11): : 1 - 21
  • [26] Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing
    Jain, Surbhi
    Xun, Guanhua
    Zhao, Huimin
    ACS SYNTHETIC BIOLOGY, 2024, 13 (10): : 3056 - 3068
  • [27] Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective
    Zhang, Debin
    Hussain, Amjad
    Manghwar, Hakim
    Xie, Kabin
    Xie, Shengsong
    Zhao, Shuhong
    Larkin, Robert M.
    Qing, Ping
    Jin, Shuangxia
    Ding, Fang
    PLANT BIOTECHNOLOGY JOURNAL, 2020, 18 (08) : 1651 - 1669
  • [28] Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems
    Taegeun Bae
    Junseok W. Hur
    Dokyoung Kim
    Junho K. Hur
    Genes & Genomics, 2019, 41 : 871 - 877
  • [29] Characterization of Cas proteins for CRISPR-Cas editing in streptomycetes
    Yeo, Wan Lin
    Heng, Elena
    Tan, Lee Ling
    Lim, Yi Wee
    Lim, Yee Hwee
    Hoon, Shawn
    Zhao, Huimin
    Zhang, Mingzi M.
    Wong, Fong Tian
    BIOTECHNOLOGY AND BIOENGINEERING, 2019, 116 (09) : 2330 - 2338
  • [30] Transgene-Free Genome Editing in Caenorhabditis elegans Using CRISPR-Cas
    Chiu, Hui
    Schwartz, Hillel T.
    Antoshechkin, Igor
    Sternberg, Paul W.
    GENETICS, 2013, 195 (03): : 1167 - 1171